Steroid 21-hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia.
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency is a common autosomal recessive disorder of cortisol biosynthesis that results in disordered sexual differentiation and somatic growth. Two-thirds of the patients with the severe, "classical" form of this disease are also unable to synthesize the mineralocorticoid hormone aldosterone and, if untreated, may die shortly after birth from renal "salt wasting" (1) . The affected enzyme is a specific cytochrome P450 (P450c21 or P45OXXIA), a heme-containing microsomal protein. The gene CYP21B, encoding this enzyme, and a pseudogene, C YP21A, are located in the HLA major histocompatibility complex on chromosome 6p, respectively adjacent to C4B and C4A, the genes encoding the fourth component of serum complement (Fig. 1A) (2, 3) [other names for the 21-hydroxylase genes are 21-OHase A/B, OH21A/B, CA21HA/B, P450C21A/B, and P450-XXIA1/2 (4) ].
CYP21A and CYP2JB are each 3.1 kilobases (kb) long and are -98% identical in exons (5, 6) . There are 11 single-base differences in exons between the genes, of which 7 result in amino acid substitutions and 1 results in premature termination of translation. The pseudogene also contains an 8-basepair (bp) deletion and a 1-bp insertion, each of which shifts the reading frame of translation. Thus, the hypothetical product of the CYP21A gene is completely nonfunctional.
About 5-10% of classical 21-hydroxylase deficiency alleles occur in association with the rare HLA haplotype A3;Bw47;DR7. This haplotype invariably carries a complete deletion of CYP21B (7) and C4B; -25% of the remaining classical alleles also carry a deletion of CYP21B (8, 9) . The mutations causing most other 21-hydroxylase deficiency alleles have not as yet been identified.
We now report that, in one mutant CYP21B gene that is not deleted, codon 172, normally ATC encoding isoleucine, has been changed to AAC encoding asparagine. While this single-base change could have resulted from a point mutation, the identical mutation is normally present in the CYP21A pseudogene. Thus, this mutant allele may represent a gene-conversion event.
MATERIALS AND METHODS Enzymes and related reagents were purchased from International Biotechnologies (New Haven, CT) and used according to the manufacturer's directions or as described (10) .
Construction of a Partial Genomic Library. High molecular weight DNA was prepared (11) from leukocytes of a patient with 21-hydroxylase deficiency and digested with BamHI. The 14-kb fraction containing the CYP21 genes was isolated by electrophoresis in agarose and by electroelution onto NA45 paper (Schleicher & Schuell). Fractionated DNA (400 ng) was ligated to 1 Ag of BamHI-digested arms of the bacteriophage A vector EMBL3 (12) and packaged in vitro into phage particles (reagents obtained from Stratagene, San Diego, CA).
Isolation and Analysis of a Mutant CYP21B Gene. The library was screened (13) for the desired insert by hybridization with pC21/3c, which contains a nearly full-length cDNA insert encoding P450c21 (6) . Clones carrying CYP21A and -B genes were distinguished by restriction mapping (Fig. 1B) . A 7-kb Xho I-BamHI fragment containing the CYP21B gene was subcloned into the corresponding sites of pIBI24. Chaintermination sequencing reactions (14) were performed with supercoiled plasmid DNA as a template (15) nucleotide primers corresponding to sequences on both strands of the normal CYP21B gene (Fig. 1C) . Transfection into Y1 Cells. Cultured Y1 mouse adrenocortical tumor cells were cotransfected as described (16) with pSV2-neo (2 ,ug) and plasmids carrying normal or mutant human CYP21B genes (15 ,ug) . After selection with G418 (GIBCO) at 400 ,ug/ml, resistant clones were pooled and maintained in selective medium.
Analysis of Expression of Transfected CYP21B Genes. The expression of the transfected genes was assessed by RNase protection assays as described (17 (19, 20) . The A partial genomic library was prepared from peripheral blood leukocyte DNA of this patient. Six bacteriophage A clones that contained CYP21 genes were isolated after screening 20,000 plaques by hybridization with pC21/3c, of which two contained CYP2JB genes (Fig. 1B) .
One of these clones was subjected to DNA sequence analysis. To rule out the possibility of artifacts arising from the use of specific sequencing primers, a characterized (6) normal CYP21B gene was analyzed in parallel with the same primers. [ GenBank entry for the CYP21 genes § based on new and reviewed data and comparison to other published sequences of these genes (5, 6, 21 (Fig. 1D) Patient H is a 7-year-old female who, when studied as an inpatient at 1 year of age, could conserve sodium at the expense of a high plasma renin/urinary aldosterone ratio. Thus, her ability to synthesize aldosterone was decreased but not absent. Patients S and 0 are 12-year-old males who have never demonstrated electrolyte disturbances or aldosterone deficiency ("simple virilizing" 21-hydroxylase deficiency). Patient I is a 26-year-old female who, at birth, had clear salt-wasting symptoms with an aldosterone deficiency that continued until age 12. She subsequently discontinued medication and has been documented to conserve sodium normally.
Because the codon 172 mutation is normally present in the CYP21A pseudogene, it seemed possible that it had been transferred to the CYP21B gene by a gene conversion event.
To determine if any of the patients with this mutation carried larger gene conversions, DNA samples were hybridized with probes corresponding to two regions in the CYP21A that flank codon 172 (Fig. 3A) . One One of the four patients (patient I) who carried the codon 172 mutation also carried an CYP21B gene that hybridized with both of these additional probes (Fig. 3B ). Hybridization analysis of her parents (data not shown) demonstrated that the CYP21B gene donated by her father carried both of these additional mutations, presumably representing a single-gene conversion encompassing at least exons [3] [4] [5] [6] (Fig. 4) .
DISCUSSION
The mutant CYP21B gene was isolated from a patient with classical 21-hydroxylase deficiency, suggesting that the mutation in codon 172 affects the synthesis, enzymatic activity, or both of the encoded P450c21 relatively severely. However, as the patients with this mutation (two of whom have a heterozygous deletion of CYP21B) retain the ability to make some aldosterone, the mutation probably does not completely abolish enzymatic function. The lower degree of compromise of aldosterone synthesis, as compared to cortisol synthesis, may relate to the much smaller relative amounts of aldosterone normally secreted by the adrenal cortex. The differences in phenotype between patient H (who has decreased but not absent ability to synthesize aldosterone) and patients 0 and S (who apparently synthesize aldosterone normally) may be due to individual variation in levels of synthesis of the mutant enzyme or to differing rates of catabolism or excretion of various steroid hormones. Similar variations in aldosterone biosynthetic capacity have been documented (22) in HLA-identical siblings with 21-hydroxylase deficiency.
Ile-172 is conserved in the P450c21 (P45OXXI) enzymes of mice (23) and cattle (24, 25) and in otherwise poorly homologous enzymes, such as steroid 17-hydroxylase (P450XVII) (26) or P450s induced in the liver by phenobarbital (P450IIB) (27) , dioxin (P450I) (28) , or steroids (P450111) (29) (Fig. 5) . This suggests that Ile-172 participates in a hydrophobic interaction that is important for maintaining the correct conformation of the enzyme. Mutation at this position to a polar residue, such as asparagine, might disrupt such an interaction.
It is unlikely that the mutation in codon 172 or an additional undetected mutation in the promoter region af- (Fig. 4) (the silent mutation, of course, could be a polymorphism in the normal population). One patient apparently carries the codon 172 mutation as part of a larger rearrangement involving at least four exons. This large gene conversion includes the 8-bp deletion in exon 3, and, because of the resulting frameshift, the encoded protein is predicted to be truncated and completely nonfunctional. The exact borders of the conversion have not been determined. Because this gene carries a 3.7-kb (not a 3.2-kb) Taq I fragment, the conversion cannot extend to the extra Taq I site near CYP21A, located 211 bp upstream of the initial ATG. The conversion also does not include the nonsense mutation in codon 318 of CYP21A (unpublished observations).
Gene conversion events may be facilitated by the presence of chi-like sequences. Chi is a sequence, usually GCTGG-GG, involved in recombination in bacteriophage A (30) . Similar sequences have been observed near recombinational hot spots in immunoglobulin genes (31) and in human and murine class I and class II genes in the major histocompatibility complex (32) . Although a single 7-bp sequence is expected to occur about once every 8000 bp in random DNA, GCTGGGG occurs six times in CYP21B and five times in CYP21A. One such site is present -50 bp away from the mutation in codon 172.
These findings suggest that gene conversion may be a frequent cause of 21-hydroxylase deficiency, a hypothesis that could be tested by hybridizing DNA from patients with additional oligonucleotide probes corresponding to each mutation normally present in the CYP21A pseudogene. In fact, three of the 20 patients carry the nonsense mutation normally found in codon 318 of the CYP21A gene (unpublished observations). If other gene conversions are equally common [however, simple point mutations will certainly account for some mutant alleles (21)], it should be possible to prenatally diagnose 21-hydroxylase deficiency by chorionic villus sampling by using a small number of oligonucleotide probes. This would be of interest in light of the possibility of prenatal therapy of this disorder to prevent abnormal sexual differentiation in female fetuses (33) .
